Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse

Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers

(2016) Ajeet Kaushik et al.   Scientific Reports

The HIV-1 transgenic rat model of neuroHIV

(2015) Michael Vigorito et al.   BRAIN BEHAVIOR AND IMMUNITY

HIV-1 Subtypes B and C Tat Differentially Impact Synaptic Plasticity Expression and Implicates HIV-Associated Neurocognitive Disorders§

(2015) Thangavel Samikkannu et al.   CURRENT HIV RESEARCH

Sustained-release nanoART formulation for the treatment of neuroAIDS

(2015) Rahul Jayant et al.   International Journal of Nanomedicine

Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS

(2015) Vidya Sagar et al.   Journal of Biomedical Nanotechnology

Microglia-derived HIV Nef+ exosome impairment of the blood–brain barrier is treatable by nanomedicine-based delivery of Nef peptides

(2015) A. D. Raymond et al.   JOURNAL OF NEUROVIROLOGY

Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice

(2015) Luisa Fiandra et al.   Nanomedicine-Nanotechnology Biology and Medicine

HIV Subtypes B and C gp120 and Methamphetamine Interaction: Dopaminergic System Implicates Differential Neuronal Toxicity

(2015) Thangavel Samikkannu et al.   Scientific Reports

Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC)

(2015) Marisela Agudelo et al.   Frontiers in Microbiology

The potential of magneto-electric nanocarriers for drug delivery

(2014) Ajeet Kaushik et al.   Expert Opinion on Drug Delivery

Enhanced blood–brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation

(2014) Hong Ding et al.   NANOTECHNOLOGY

Brain-Targeted Delivery of Trans-Activating Transcriptor-Conjugated Magnetic PLGA/Lipid Nanoparticles

(2014) Xiangru Wen et al.   PLoS One

Towards nanomedicines for neuroAIDS

(2014) Vidya Sagar et al.   REVIEWS IN MEDICAL VIROLOGY

Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder

(2014) Venkata Subba Atluri et al.   Molecular Brain

An Integrated Microrobotic Platform for On-Demand, Targeted Therapeutic Interventions

(2013) Stefano Fusco et al.   ADVANCED MATERIALS

Synaptic dysfunction in human immunodeficiency virus type-1-positive subjects: inflammation or impaired neuronal plasticity?

(2013) V. Avdoshina et al.   JOURNAL OF INTERNAL MEDICINE

Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study

(2013) Sudheesh Pilakka-Kanthikeel et al.   PLoS One

Human Synaptic Plasticity Gene Expression Profile and Dendritic Spine Density Changes in HIV-Infected Human CNS Cells: Role in HIV-Associated Neurocognitive Disorders (HAND)

(2013) Venkata Subba Rao Atluri et al.   PLoS One

Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers

(2013) Madhavan Nair et al.   Nature Communications

Effect of magnet implant on iron biodistribution of Fe@C nanoparticles in the mouse

(2012) Elvira Escribano et al.   ARCHIVES OF PHARMACAL RESEARCH

HIV-1, Methamphetamine and Astrocyte Glutamate Regulation: Combined Excitotoxic Implications for Neuro-AIDS

(2012) Irma E. Cisneros et al.   CURRENT HIV RESEARCH

Magnetic targeting of nanoparticles across the intact blood–brain barrier

(2012) Seong Deok Kong et al.   JOURNAL OF CONTROLLED RELEASE

Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis

(2012) Dionna W. Williams et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells

(2012) Debjani Guha et al.   Journal of Neuroinflammation

Insight into Serum Protein Interactions with Functionalized Magnetic Nanoparticles in Biological Media

(2012) Hilda T. R. Wiogo et al.   LANGMUIR

Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat

(2011) AH Shin et al.   BRITISH JOURNAL OF PHARMACOLOGY

Human immunodeficiency virus type 1 Tat modulates proliferation and differentiation of human neural precursor cells: implication in NeuroAIDS

(2010) Mamata Mishra et al.   JOURNAL OF NEUROVIROLOGY

Activation of the Oxidative Stress Pathway by HIV-1 Vpr Leads to Induction of Hypoxia-inducible Factor 1α Expression

(2009) Satish L. Deshmane et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways

(2009) Honghong Yao et al.   JOURNAL OF NEUROVIROLOGY

Morphine enhances Tat-induced activation in murine microglia

(2009) Sirosh M Bokhari et al.   JOURNAL OF NEUROVIROLOGY

HIV-1 Tat Protein-Induced Rapid and Reversible Decrease in [3H]Dopamine Uptake: Dissociation of [3H]Dopamine Uptake and [3H]2 -Carbomethoxy-3- -(4-fluorophenyl)tropane (WIN 35,428) Binding in Rat Striatal Synaptosomes

(2009) J. Zhu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS